297 related articles for article (PubMed ID: 15280777)
1. Cost-effectiveness of nevirapine to prevent mother-to-child HIV transmission in eight African countries.
Sweat MD; O'Reilly KR; Schmid GP; Denison J; de Zoysa I
AIDS; 2004 Aug; 18(12):1661-71. PubMed ID: 15280777
[TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.
Marseille E; Kahn JG; Mmiro F; Guay L; Musoke P; Fowler MG; Jackson JB
Lancet; 1999 Sep; 354(9181):803-9. PubMed ID: 10485721
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of strategies to reduce mother-to-child HIV transmission in Mexico, a low-prevalence setting.
Rely K; Bertozzi SM; Avila-Figueroa C; Guijarro MT
Health Policy Plan; 2003 Sep; 18(3):290-8. PubMed ID: 12917270
[TBL] [Abstract][Full Text] [Related]
4. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of antiviral drug therapy to reduce mother-to-child HIV transmission in sub-Saharan Africa.
Marseille E; Kahn JG; Saba J
AIDS; 1998 May; 12(8):939-48. PubMed ID: 9631148
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of interventions to reduce vertical HIV transmission from pregnant women who have not received prenatal care.
Mrus JM; Tsevat J
Med Decis Making; 2004; 24(1):30-9. PubMed ID: 15005952
[TBL] [Abstract][Full Text] [Related]
7. Potential cost-effectiveness of maternal and infant antiretroviral interventions to prevent mother-to-child transmission during breast-feeding.
Maclean CC; Stringer JS
J Acquir Immune Defic Syndr; 2005 Apr; 38(5):570-7. PubMed ID: 15793368
[TBL] [Abstract][Full Text] [Related]
8. Coverage of nevirapine-based services to prevent mother-to-child HIV transmission in 4 African countries.
Stringer EM; Ekouevi DK; Coetzee D; Tih PM; Creek TL; Stinson K; Giganti MJ; Welty TK; Chintu N; Chi BH; Wilfert CM; Shaffer N; Dabis F; Stringer JS;
JAMA; 2010 Jul; 304(3):293-302. PubMed ID: 20639563
[TBL] [Abstract][Full Text] [Related]
9. The value of contraception to prevent perinatal HIV transmission.
Reynolds HW; Janowitz B; Homan R; Johnson L
Sex Transm Dis; 2006 Jun; 33(6):350-6. PubMed ID: 16505747
[TBL] [Abstract][Full Text] [Related]
10. The global strategy to eliminate HIV infection in infants and young children: a seven-country assessment of costs and feasibility.
Nakakeeto ON; umaranayake L
AIDS; 2009 May; 23(8):987-95. PubMed ID: 19425224
[TBL] [Abstract][Full Text] [Related]
11. National and provincial estimated costs and cost effectiveness of a programme to reduce mother-to-child HIV transmission in South Africa.
Wilkinson D; Floyd K; Gilks CF
S Afr Med J; 2000 Aug; 90(8):794-8. PubMed ID: 11022629
[TBL] [Abstract][Full Text] [Related]
12. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
; de Vincenzi I
Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania.
Sweat M; Gregorich S; Sangiwa G; Furlonge C; Balmer D; Kamenga C; Grinstead O; Coates T
Lancet; 2000 Jul; 356(9224):113-21. PubMed ID: 10963247
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the cost-effectiveness of combination antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Uganda.
Kuznik A; Lamorde M; Hermans S; Castelnuovo B; Auerbach B; Semeere A; Sempa J; Ssennono M; Ssewankambo F; Manabe YC
Bull World Health Organ; 2012 Aug; 90(8):595-603. PubMed ID: 22893743
[TBL] [Abstract][Full Text] [Related]
15. First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial.
Ciaranello AL; Lockman S; Freedberg KA; Hughes M; Chu J; Currier J; Wood R; Holmes CB; Pillay S; Conradie F; McIntyre J; Losina E; Walensky RP;
AIDS; 2011 Feb; 25(4):479-92. PubMed ID: 21293199
[TBL] [Abstract][Full Text] [Related]
16. Costs and benefits of multidrug, multidose antiretroviral therapy for prevention of mother-to-child transmission of HIV in the Dominican Republic.
Schmidt NC; Roman-Pouriet J; Fernandez AD; Beck-Sagué CM; Leonardo-Guerrero J; Nicholas SW
Int J Gynaecol Obstet; 2012 Mar; 116(3):219-22. PubMed ID: 22196992
[TBL] [Abstract][Full Text] [Related]
17. Mass treatment with nevirapine to prevent mother-to-child transmission of HIV/AIDS in sub-Saharan African countries.
Hashimoto H; Kapiga SH; Murata Y
J Obstet Gynaecol Res; 2002 Dec; 28(6):313-9. PubMed ID: 12512929
[TBL] [Abstract][Full Text] [Related]
18. Programmes for the prevention of mother-to-child HIV infection transmission have made progress in Yunnan Province, China, from 2006 to 2015: a cost effective and cost-benefit evaluation.
Wang X; Guo G; Zheng J; Lu L
BMC Infect Dis; 2019 Jan; 19(1):64. PubMed ID: 30654744
[TBL] [Abstract][Full Text] [Related]
19. Integrating prevention of mother-to-child HIV transmission (PMTCT) programmes with other health services for preventing HIV infection and improving HIV outcomes in developing countries.
Tudor Car L; van-Velthoven MH; Brusamento S; Elmoniry H; Car J; Majeed A; Atun R
Cochrane Database Syst Rev; 2011 Jun; (6):CD008741. PubMed ID: 21678382
[TBL] [Abstract][Full Text] [Related]
20. The cost effectiveness of a single-dose nevirapine regimen to mother and infant to reduce vertical HIV-1 transmission in sub-Saharan Africa.
Marseille E; Kahn JG; Mmiro F; Guay L; Musoke P; Fowler MG; Jackson JB
Ann N Y Acad Sci; 2000 Nov; 918():53-6. PubMed ID: 11131734
[No Abstract] [Full Text] [Related]
[Next] [New Search]